Novel 5-HT2A Receptor Agonists (incl. non-hallucinogenic neuroplastogens)therapy(Atai Life Sciences NV)

N/A

Report date: 2025/10/20 14:18:10

Base Information

Drug NameNovel 5-HT2A Receptor Agonists (incl. non-hallucinogenic neuroplastogens)therapy(Atai Life Sciences NV)
Drug Alias NameN/A
ClassificationOther
Mechanisms of ActionSerotonin 2a (5-HT2a) receptor agonists
TargetsSerotonin 2a (5-HT2a) receptor
Therapy Area/IndicationsPsychedelic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlands
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAtai Life Sciences NV
China Registration ClassN/A

Develop Information

Active CompaniesAtai Life Sciences NV
Inactive CompaniesN/A
Active IndicationsPsychedelic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A